Strategic Partnerships GATC Biotech recently expanded its research capabilities through collaborations with Fraunhofer Institute, Pusan National University, and Gene In Corporation, Ltd., presenting opportunities to offer tailored biotechnology solutions and bioinformatics services to academic and industry partners.

Technological Innovation The company has launched multiple advanced sequencing services including GATCLIQUID and full-length transcript isoform characterization, indicating a focus on innovative genome analysis tools that can be valuable offerings for research institutions and biotech firms seeking cutting-edge diagnostic solutions.

Growth through Acquisition Since being acquired by Eurofins in 2017, GATC Biotech has become part of a global leader in bio-analytical testing, opening channels for cross-selling and expanding sales in specialized genomic and diagnostic markets within the broader Eurofins network.

Market Focus GATC’s emphasis on DNA sequencing, bioinformatics, and diagnostic services positions it well to target pharmaceutical, diagnostics, and academic research sectors that require comprehensive sequencing solutions, creating potential sales opportunities in custom genome projects and diagnostic testing.

Emerging Revenue Opportunities With a focus on developing innovative sequencing technologies and diagnostic services, GATC presents upselling potential for existing clients in targeted high-growth markets such as microbial diversity analysis, circulating DNA, and genome diagnostics.